Fylde and Wyre Policies

Click each header to expand its content

Commissioning Policies

NameSizeHits
Application Amendment Waiver of Policies for the Comm of Appropriate Effective and Priority Health Care 0.4 MB63
Commissioning Policies Introduction Document 89 KB88
Considering Applications For Exceptionality 0.3 MB123
General Policy IFR Decision Making 0.4 MB83
Policy for Assisted Conception Services 0.3 MB134
Policy for Benign Skin Lesion (updated September 2019) 0.2 MB0
Policy for Carpal Tunnel Syndrome (updated September 2019) 0.2 MB0
Policy for Chalazia Removal 0.2 MB53
Policy for Choice of Service Provide 0.2 MB82
Policy For Commissioning Spinal Injection Radiofrequency Denervation For Low Back Pain 0.6 MB77
Policy for Complementary and Alternative Therapies 88 KB71
Policy for Complex Cases 0.2 MB66
Policy for Cosmetic Procedures (updated September 2019) 0.2 MB1
Policy for Dilatation and Curettage 45 KB50
Policy for Dupuytren's contracture 0.3 MB59
Policy for Endoscopic Procedures on the Knee Joint Cavity 0.2 MB65
Policy for excision of the uterus 0.1 MB66
Policy for ganglia excision 0.2 MB47
Policy for Glucose Monitoring Devices (March 19 amends) 0.3 MB149
Policy for Grommets (updated September 2019) 0.2 MB0
Policy for Gynaecomastia (updated September 2019) 0.2 MB0
Policy for Haemorrhoid surgery 0.2 MB44
Policy for Hip Arthroscopy 42 KB77
Policy for hysteroscopy 44 KB53
Policy for hysteroscopy 0.1 MB24
Policy for insulin pump provision 0.1 MB56
Policy for Lumbar spine procedures 0.3 MB54
Policy for Male Circumcision 0.2 MB83
Policy for Monitoring and Enforcing CCG Policies 0.1 MB66
Policy for photorefractive surgery 0.1 MB59
Policy for Reversal of Sterilisation 0.1 MB75
Policy for Reversal of Sterilisation 0.1 MB28
Policy for services that are the subject of guidance from NICE 0.1 MB91
Policy for snoring surgery 0.2 MB44
Policy for Specified Expensive Services 0.1 MB64
Policy for Specified Non-clinical issues 0.1 MB65
Policy for Specified Services for which provision in service agreements may be limited 0.2 MB83
Policy for testing for Malignant Hyperthermia 0.1 MB82
Policy for Tonsillectomy (updated September 2019) 0.2 MB0
Policy for Varicose Veins 0.1 MB151
Policy for varicose veins 0.1 MB32
Policy Process map appeals 0.1 MB63
Policy Spinal Cord Stimulation 38 KB86
Policy subacromial decompression 0.2 MB48
Statement Of Principles 0.3 MB64

Commissioning Policy summaries

Corporate Policies

Information Governance

Medicines Optimisation

NameSizeHits
Actipatch for pain management 0.6 MB131
Albiglutide for type-2 diabetes mellitus 0.3 MB99
Alprostadil Cream For ED 0.3 MB72
Azelastine Fluticasone (Dymista) Nasal Spray 0.1 MB107
Bazedoxifene for oestrogen deficiency symptoms 0.3 MB87
Botulinum Toxin A for Spasticity and Contracture of the joint 0.3 MB83
Brimonidine For Erythema Of Rosacea 0.1 MB78
Brivaracetam for epilepsy 0.3 MB82
Budesonide multimatrix MMX 9mg prolonged release tablets 0.2 MB104
Certolizumab For Psoriatic Arthritis 0.1 MB64
Co-Proxamol For pain management 0.3 MB167
Co-trimoxazole for the prophylaxis of pneumocystis jirovecii (pneumocystis carinii) infections 0.3 MB78
Co-trimoxazole Prophylaxis of Primary and Secondary Spontaneous Bacterial Peritonitis (SBP) 0.1 MB85
Colesevelam (Cholestagel® ) For combination or monotherapy for familial hypercholesterolaemia 0.3 MB85
Colistimethate sodium/Colistin sulfomethate sodium (Colomycin® ) For non-Cystic Fibrosis in Patients with Bronchiectasis Colonised with Pseudomonas Aeruginosa 0.2 MB47
Conditions for which over the counter items should not routinely be prescribed in primary care 0.9 MB167
Daily selective serotonin re-uptake inhibitors (SSRIs) for the treatment of premature ejaculation (PE) 0.2 MB60
Dapoxetine for the treatment of premature ejaculation (PE) 0.2 MB58
Denosumab for GIO 0.2 MB45
Dulaglutide for the treatment of Type II Diabetes Mellitus in adults 0.3 MB89
Eflornithine-cream-for-facial-hirsutism 0.2 MB78
Eltrombopag For Thrombocytopenia In Hepatitis C 0.1 MB50
Eslicarbazepine For Focal Seizures 0.1 MB67
Evolocumab (Repatha SureClick® ) For prevention of cardiac events in patients with CHD and a history of ACS, in combination with a statin 0.1 MB82
Ferric Maltol 30mg Capsules in Adults for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease 0.3 MB81
Fluorouracil-5-cream-for-basal-cell-carcinomas 0.1 MB47
Gluten-Free-Food-Products 0.3 MB79
Guanfacine-for-ADHD 0.3 MB77
Imiquimod-5-cream-for-basal-cell-carcinomas 0.2 MB71
Insulin Degludec And Liraglutide 0.2 MB62
Insulin-Aspart-for-Diabetes-Mellitus 0.3 MB74
Insulin-Degludec-for-DM 0.3 MB80
Insulin-Detemir-for-DM 0.2 MB53
Insuline-Glargine-for-T1DM 0.3 MB60
Insuline-Glargine-for-T2DM 0.3 MB64
Invicorp-injection-for-erectile-dysfunction 0.3 MB91
Ivermectin-cream-for-rosacea 0.3 MB75
JIA Policy For Adults (Version 1.0) 0.2 MB59
Lamotrigine-for-trigeminal-neuralgia 0.3 MB72
Lamotrigine-for-trigeminal-neuralgia 2 0.3 MB90
Levonorgestrel 13.5mg IUD 0.3 MB54
Lidocaine Plasters For PHN 0.2 MB64
Lidocaine-plasters-for-unlicensed-indications 0.3 MB111
Liothyronine-for-refractory-hypothyroidism 0.2 MB95
Liraglutide-for-obesity 0.3 MB72
Lisdexamfetamine-for-ADHD-in-adults 0.3 MB77
Lisdexamfetamine-for-ADHD-update 0.3 MB70
Lurasidone-for-Schizophrenia 0.3 MB86
Magnaspartate For Hypomagnesaemia 0.3 MB91
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 0.2 MB61
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 2 0.2 MB47
Midazolam-Epistatus-for-seizures 0.2 MB74
Opicapone-for-Parkinsons-disease-v2 0.5 MB89
Ospemifene for VVA 0.2 MB69
Oxycodone-Naloxone-for-Restless-legs 0.3 MB64
Paravit-CF-for-dietary-management-of-patients-with-cystic-fibrosis 0.2 MB196
Patiromer-for-hyperkalaemia 0.3 MB61
Patiromer-for-hyperkalaemia 2 0.3 MB75
Phosphodiesterase Type-5 Inhibitors 0.2 MB56
Pitolisant-for-Narcolepsyv2 0.3 MB60
Policy On Brand Inhaler Prescribing 0.3 MB80
Probiotics And VSL 0.3 MB67
Relvar Ellipta for COPD and asthma in adults 63 KB58
Rituximab-for-AIHA 0.4 MB79
Rituximab-for-ITP 0.4 MB70
Rivaroxaban-10mg-for-DVT-and-PE-and-extended-use 0.1 MB77
Safinamide-for-Parkinsons-disease 0.3 MB84
Second Line Anti-TNF For PsA 0.2 MB74
Second-generation-LA-antipsychotics 0.3 MB83
Secukinumab-for-Palmoplantar-psoriasis 0.3 MB56
Secukinumab-for-Palmoplantar-psoriasis 2 0.3 MB69
Semaglutide for type 2 DM 0.2 MB42
Silk Garments For Eczema And Dermatitis 0.2 MB58
Simbrinza for chronic open angle glaucoma 0.1 MB56
Sodium Oxybate for Narcolepsy with Cataplexy 0.3 MB74
Spironolactone For Acne 0.1 MB72
Subcutaneous Depot Medroxyprogesterone Acetate 0.1 MB69
Tadalafil daily 0.3 MB86
Tapentadol for neuropathic pain in non-palliative care 0.4 MB80
Tapentadol for non-specific pain 0.2 MB73
Testosterone For Female Sexual Dysfunction 0.1 MB49
Tiotropium For Asthma 0.2 MB53
Tocilizumab SC For RA 0.1 MB52
Trelegy inhaler for COPD 0.3 MB74
Trimbow inhaler for COPD 0.4 MB81
Trimbow-inhaler-for-COPD 0.4 MB6
Ulipristal acetate for uterine fibroids 0.5 MB74
Umeclidinium For COPD 0.2 MB55
Vedolizumab For Crohn's Disease 0.2 MB46
Vesomni For Benign Prostatic Hyperplasia 0.1 MB55
Vitamins (inc Renavit) For Dialysis 0.3 MB82
Waterproof Cast Cover Policy 0.1 MB97
Xonvea for nausea and vomiting in pregnancy 0.1 MB41

Last updated on 17 September 2019 at 15:48 by communications manager